Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report

Read full text Summarise with VIRAT
Authors: Rima Akil, Süreyya Yiğit Kaya, Hüseyin Saffet Beköz, Aslı Çakır, Leylagül Kaynar
Cited by: 0
References: 8

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

To the Editor,Hepatosplenic T-cell lymphoma (HSTCL) is a rare and aggressive subtype of peripheral T-cell lymphoma (PTCL) that typically affects young male patients and is characterized by hepatosplenomegaly, cytopenias, and poor outcomes.We report a patient with HSTCL achieving complete remission (CR) following lenalidomide-augmented IVAC/ICE (IVAC: ifosfamide, etoposide, high-dose cytarabine; ICE: ifosfamide, carboplatin, etoposide) and consolidation with allogeneic hematopoietic stem cell transplantation (allo-HSCT).A 21-year-old male patient presented in September 2022 with complaints of fatigue, weakness, and fever.Laboratory evaluations revealed pancytopenia and ultrasound showed hepatosplenomegaly (spleen: 17 cm; liver: 19 cm).A bone marrow aspiration biopsy was performed for diagnosis and revealed HSTCL (γδ T-cell phenotype).Positron emission tomographycomputed tomography (PET-CT) performed for staging showed no fluorodeoxyglucose-uptake lesions in any region, only diffuse non-homogeneous bone marrow involvement.Cytogenetic analysis revealed no structural or numerical abnormalities; however, fluorescence in situ hybridization detected trisomy 8q24 in 30% of cells and next-generation sequencing identified a KRAS mutation with a variant allele frequency of 20.7%.Cerebrospinal fluid cytology and flow cytometry were negative for central nervous system involvement.

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment Viral-associated cancers and disorders Cutaneous lymphoproliferative disorders research

Publication details

Journal / source
Turkish Journal of Hematology
Publication date
31 March 2026
Language
EN